WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · SB 299

Legislative bill overview

SB 299 establishes regulatory requirements for the sale of kratom products in Ohio. The bill would create a framework governing how kratom—a botanical substance derived from the Mitragyna speciosa plant—can be marketed, labeled, and sold within the state. While the bill's specific provisions are not detailed in the available information, such legislation typically addresses age restrictions, product labeling, ingredient transparency, and vendor licensing.

Why is this important

Kratom operates in a regulatory gray area at the federal level, leading to inconsistent state-by-state rules. Ohio's action would clarify the legal status of kratom sales for consumers, retailers, and law enforcement, potentially affecting thousands of vendors and hundreds of thousands of users. The bill reflects growing state interest in establishing clear standards for botanical products that lack comprehensive FDA oversight.

Potential points of contention

  • Scope of regulation: Disagreement over whether kratom should be treated as a dietary supplement, alternative medicine, or controlled substance, with each classification carrying different regulatory burdens
  • Public health vs. commerce interests: Tension between consumer access advocates and public health officials concerned about kratom's safety profile, dependency potential, and lack of standardized dosing
  • Industry compliance costs: Small retailers and vendors may face financial barriers to meet new licensing, testing, and labeling requirements, potentially consolidating the market

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.